Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aloenin A
2. 38412-46-3
3. Aloearbonaside
4. An96cw6csu
5. 6-[4-hydroxy-2-methyl-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-4-methoxypyran-2-one
6. 2h-pyran-2-one, 6-[2-(.beta.-d-glucopyranosyloxy)-4-hydroxy-6-methylphenyl]-4-methoxy-
7. 2h-pyran-2-one, 6-(2-(.beta.-d-glucopyranosyloxy)-4-hydroxy-6-methylphenyl)-4-methoxy-
8. Mfcd08275450
9. Unii-an96cw6csu
10. Aloenin A, Analytical Standard
11. Megxp0_001070
12. Acon0_001054
13. Acon1_000758
14. Dtxsid10191751
15. Chebi:176869
16. Hy-n0495
17. Zinc6070013
18. Aloenin, >=95% (lc/ms-elsd)
19. Ncgc00169388-01
20. Ac-34455
21. Cs-0009016
22. A831563
23. Brd-k20250782-001-01-4
24. 2h-pyran-2-one, 6-(2-(beta-d-glucopyranosyloxy)-4-hydroxy-6-methylphenyl)-4-methoxy-
25. 4-methoxy-6-(2'-beta-glucopyranosyloxy-4'-hydroxy-6'-methylphenyl)-2-pyrone
26. 6-[2-(beta-d-glucopyranosyloxy)-4-hydroxy-6-methylphenyl]-4-methoxy-2h-pyran-2-one
27. 6-(2-(.beta.-d-glucopyranosyloxy)-4-hydroxy-6-methylphenyl)-4-methoxy-2h-pyran-2-one
28. 6-[2-[(2s,3r,4s,5s,6r)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-4-oxidanyl-phenyl]-4-methoxy-pyran-2-one
29. 6-[4-hydroxy-2-methyl-6-[[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]phenyl]-4-methoxy-2-pyranone
30. Ncgc00169388-03!6-[4-hydroxy-2-methyl-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-4-methoxypyran-2-one
Molecular Weight | 410.4 g/mol |
---|---|
Molecular Formula | C19H22O10 |
XLogP3 | 0 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 5 |
Exact Mass | 410.12129689 g/mol |
Monoisotopic Mass | 410.12129689 g/mol |
Topological Polar Surface Area | 155 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 661 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Aloenin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aloenin, including repackagers and relabelers. The FDA regulates Aloenin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aloenin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aloenin supplier is an individual or a company that provides Aloenin active pharmaceutical ingredient (API) or Aloenin finished formulations upon request. The Aloenin suppliers may include Aloenin API manufacturers, exporters, distributors and traders.
Aloenin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aloenin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aloenin GMP manufacturer or Aloenin GMP API supplier for your needs.
A Aloenin CoA (Certificate of Analysis) is a formal document that attests to Aloenin's compliance with Aloenin specifications and serves as a tool for batch-level quality control.
Aloenin CoA mostly includes findings from lab analyses of a specific batch. For each Aloenin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aloenin may be tested according to a variety of international standards, such as European Pharmacopoeia (Aloenin EP), Aloenin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aloenin USP).
LOOKING FOR A SUPPLIER?